跳至主要内容
临床试验/NCT06217718
NCT06217718已完成不适用

The Effect of Empowerment Model-Based Telenursing Interventions in Empowering Patients With COPD

Zahide Aksoy1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年6月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
COPD Empowerment Scale

研究概览

简要总结

The aim of this study is to evaluate the effect of telenursing interventions based on the empowerment model in empowering patients with COPD.

详细描述

Patient empowerment is gaining importance and popularity day by day as it can be sustained through telehealth applications. The importance of using communication technologies in providing health care services has become more evident during the COVID-19 pandemic. When integrated into healthcare, technology-centric services provide continuous and easily accessible health data for patients and help facilitate self-monitoring. With tele-nursing, COPD patients can be strengthened in health literacy by teaching them how to access accurate and reliable resources. Through tele-nursing, online support groups and forums can be created among COPD patients so that patients can share their experiences with each other. In this way, social support is provided to patients who have to remain in social isolation due to their illness.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

盲法说明

In order to prevent selection bias in the study, the assignment to the experimental and control groups will be made on a computer by a person who is unfamiliar with the research process. Individuals included in the study will not be told whether they are in the experimental or control group. The analysis of the data will be done by a statistics expert who is outside the research process.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Having a confirmed COPD diagnosis for at least one year
  • •being literate,
  • •Having the cognitive and mental competence to answer questions,
  • •Being able to use a mobile phone,
  • •Disease symptoms are at a level that does not interfere with communication,
  • •Being in COPD Stage 2 and Stage 3 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD: Global Initiative for Chronic Obstructive Lung Disease) criteria (30% ≤ FEV1 <80% (of expected)),

排除标准

  • •The disease is in the acute exacerbation period,
  • •Dyspnea is at a level that prevents cooperation,
  • •Having sensory loss regarding vision, hearing and speech,
  • •Refusal to sign informed consent forms
  • •It is the refusal of the research to complete the data collection tools.

研究组 & 干预措施

Telenursing Interventions Group

Experimental

Participants in this group will receive five hours of face-to-face empowerment training. After the training, the experimental group will be monitored remotely by the researcher nurse via tele-nursing interventions for 12 weeks. Participants will be given a pulse oximeter, symptom diary, action plan, oxygen saturation-pulse monitoring chart. Participants will be asked to measure their oxygen saturation and pulse once a day for 12 weeks and record it on the chart. Participants will also be asked to record their complaints in their symptom diary. Participants will be called by the researcher every two weeks (on Thursdays) and informative and reminding text messages prepared specifically for the disease will be sent to the participants three times a week for 12 weeks. Participants will be able to reach the researchers by phone whenever they need.

干预措施: Telenursing Interventions (Other)

No Intervention Group

No Intervention

Participants in this group will be given a pulse oximeter, symptom diary, action plan, oxygen saturation-pulse monitoring chart. No intervention will be taken.

结局指标

主要结局

COPD Empowerment Scale

时间窗: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

A 31-item scale that evaluates the impact of interventions on individuals with COPD.

次要结局

  • COPD Assesment Test(Pre-test, Post-test (3rd month), Follow-up Test (6th month))
  • Modified Barthel Index(Pre-test, Post-test (3rd month), Follow-up Test (6th month))
  • Lung Function Test(Pre-test, Post-test (3rd month), Follow-up Test (6th month))
  • Number of hospital admissions due to COPD exacerbation(Pre-test, Post-test (3rd month), Follow-up Test (6th month))
  • Modified Medical Research Council(Pre-test, Post-test (3rd month), Follow-up Test (6th month))
  • Inhaler Device Use Skill Scale(Pre-test, Post-test (3rd month), Follow-up Test (6th month))
  • Number of hospitalizations due to COPD exacerbation(Pre-test, Post-test (3rd month), Follow-up Test (6th month))

研究者

发起方
Zahide Aksoy
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zahide Aksoy

Lecturer

Marmara University

研究点 (1)

Loading locations...

相似试验